Neurovalens

Neurovalens is a UK medical device company making groundbreaking neurostimulation technology that offers clinically proven, non-invasive solutions to some of the world’s most significant health challenges.

The revolutionary at-home treatments for Chronic Insomnia and Generalized Anxiety Disorder were awarded FDA clearance as prescription issued Class II medical devices in October 2023 (Modius Sleep) and March 2024 (Modius Stress).